Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Model-supported patient stratification using multi-objective synergy optimization in combination therapy.

Mathematical biosciences·2026
Same author

Delaying cancer progression by integrating toxicity constraints in a model of adaptive therapy.

NPJ systems biology and applications·2026
Same author

The interaction between dynamic ligand signaling and epigenetics in Notch-induced cancer metastasis.

Physical biology·2025
Same author

Energy constraints and neural strategy transitions in Alzheimer's: A game-theoretic model.

Journal of theoretical biology·2025
Same author

Using Virtual Patients to Evaluate Dosing Strategies for Bispecifics With a Bell-Shaped Efficacy Curve.

CPT: pharmacometrics & systems pharmacology·2025
Same author

Integrated Population Pharmacokinetic, Pharmacodynamic, and Safety Analyses to Inform Dosage Selection in the Clinical Development of the ATR Inhibitor Tuvusertib.

Clinical pharmacology and therapeutics·2025

Related Experiment Video

Updated: Jun 27, 2026

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
09:28

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Published on: February 2, 2013

15.2K

Quantitative Pharmacology Methods for Bispecific T Cell Engagers.

Mahdiar Sadeghi1,2, Irina Kareva2,3, Gleb Pogudin4

  • 1Department of Electrical and Computer Engineering, Northeastern University, Boston, MA, USA.

Bulletin of Mathematical Biology
|May 24, 2025
PubMed
Summary
This summary is machine-generated.

T Cell Engagers (TCEs) link immune and cancer cells for enhanced efficacy. Optimizing TCE binding kinetics and target properties maximizes the formation of the drug-target trimer in the tumor microenvironment (TME).

Keywords:
IdentifiabilityModel-driven antibody designODE modelsQspSystems biology

More Related Videos

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.8K
Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
10:19

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

1.3K

Related Experiment Videos

Last Updated: Jun 27, 2026

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
09:28

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Published on: February 2, 2013

15.2K
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.8K
Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
10:19

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

1.3K

Area of Science:

  • Immunology
  • Pharmacology
  • Computational Biology

Background:

  • T Cell Engagers (TCEs) are a novel immuno-oncology therapy bypassing antigen presentation.
  • TCE efficacy relies on simultaneous binding to both immune and cancer cells within the tumor microenvironment (TME).
  • Maximizing the formation of the drug-target trimer is crucial for enhancing TCE therapeutic effects.

Purpose of the Study:

  • To quantitatively investigate how TCE design and target properties influence ternary complex concentration and biodistribution.
  • To explore the impact of binding kinetics on TCE efficacy.
  • To assess the utility of pre-clinical data for estimating TCE binding affinities.

Main Methods:

  • Development of a simplified mathematical model for drug-target interactions, inspired by the "three-body" problem.
  • Application of parameter identifiability analysis to steady-state data.
  • Analysis of kinetic features of existing clinical and developmental TCE antibodies.
  • Evaluation of a quantitative pharmacology model incorporating peripheral drug disposition.

Main Results:

  • Steady-state data is sufficient for estimating TCE binding affinity to both targets.
  • The study identified common kinetic features among various TCE antibodies.
  • The model provides insights into optimizing TCE design for improved efficacy.

Conclusions:

  • Mathematical modeling is a valuable tool for understanding and optimizing T Cell Engager therapies.
  • Binding kinetics and target properties significantly impact TCE performance in the TME.
  • This research supports the development of more effective immuno-oncology treatments.